Patents-Review.com
🔗 Permalink
Inventor profile of:

Daniel Korr

City:

Berlin

Country:

Germany

Published Applications:

20

Last publication date:

2026-02-05

Top Assignees for applications by Daniel Korr

The entities that hold a legal rights for patent applications filed by inventor Korr Daniel:

Recent patent applications by Korr Daniel

Daniel Korr from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-05
US20260035365A1
Chemistry; metallurgy

1H-PYRROLO[3,2-B]PYRIDINE DERIVATIVES AS IRREVERSIBLE INHIBITORS OF MUTANT EGFR FOR THE TREATMENT OF CANCER

 #2 | 2025-05-01
US20250136599A1
Chemistry; metallurgy

4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS

 #3 | 2024-09-19
US20240307362A1
Human necessities

4H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDS

 #4 | 2024-08-29
US20240287048A1
Chemistry; metallurgy

SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER

 #5 | 2024-08-22
US20240279207A1
Chemistry; metallurgy

SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER

 #6 | 2023-12-28
US20230416249A1
Chemistry; metallurgy

N-[2-({4-[3-(ANILINO)-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]PYRIDIN-3-YL)OXY)ETHYL]PROP-2-ENAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER

 #7 | 2023-03-02
US20230064983A1
Human necessities

3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER

 #8 | 2022-12-01
US20220378762A1
Human necessities

4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES

 #9 | 2022-09-22
US20220298157A1
Chemistry; metallurgy

4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS

 #10 | 2022-07-21
US20220226279A1
Human necessities

ACYL SULFONAMIDES FOR TREATING CANCER

 #11 | 2022-05-24
US16758018
Chemistry; metallurgy

4H-pyrrolo[3,2-c]pyridin-4-one derivatives

 #12 | 2020-04-23
US20200123147A1
Chemistry; metallurgy

THIAZOLE COMPOUNDS USEFUL AS PRMT5 INHIBITORS

 #13 | 2015-02-05
US20150038485A1
Chemistry; metallurgy

Heterocyclyl aminoimidazopyridazines

 #14 | 2014-09-25
US20140288069A1
Chemistry; metallurgy

AMINO-SUBSTITUTED IMIDAZOPYRIDAZINES AS MKNK1 KINASE INHIBITORS

 #15 | 2014-07-10
US20140194430A1
Human necessities

Substituted aminoimidazopyridazines

 #16 | 2009-01-29
US20090029954A1
Human necessities

PROGESTERONE-RECEPTOR ANTAGONIST FOR USE IN BRCA ALONE OR AS COMBINATION WITH ANTIESTROGEN

 #17 | 2008-12-18
US20080311594A1
Physics

USE OF FIBROBLAST GROWTH FACTOR 7 (Fgf7) AND OF THE RECEPTOR Fgfr2b AS BIOMARKERS

 #18 | 2008-10-30
US20080268041A1
Human necessities

COMBINATION OF PROGESTERONE-RECEPTOR ANTAGONIST TOGETHER WITH NONE-STEROIDAL ANTIESTROGEN FOR USE IN BRCA MEDIATED DISEASES

 #19 | 2008-10-23
US20080261933A1
Human necessities

COMBINATION OF PROGESTERONE-RECEPTOR ANTAGONIST TOGETHER WITH A LUTEIN-HORMONE-RELEASING HORMONE AGONIST AND ANTAGONIST FOR USE IN BRCA MEDIATED DISEASES

 #20 | 2008-10-23
US20080261929A1
Human necessities

COMBINATION OF PROGESTERONE-RECEPTOR ANTAGONIST TOGETHER WITH AN AROMATASE INHIBITOR FOR USE IN BRCA MEDIATED DISEASES
InventorID:

833229 ⎘